skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia

Orlando, Elena J ; Han, Xia ; Tribouley, Catherine ; Wood, Patricia A ; Leary, Rebecca J ; Riester, Markus ; Levine, John E ; Qayed, Muna ; Grupp, Stephan A ; Boyer, Michael ; De Moerloose, Barbara ; Nemecek, Eneida R ; Bittencourt, Henrique ; Hiramatsu, Hidefumi ; Buechner, Jochen ; Davies, Stella M ; Verneris, Michael R ; Nguyen, Kevin ; Brogdon, Jennifer L ; Bitter, Hans ; Morrissey, Michael ; Pierog, Piotr ; Pantano, Serafino ; Engelman, Jeffrey A ; Winckler, Wendy

Nature medicine, 2018-10, Vol.24 (10), p.1504-1506 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
Material Type:
Artigo 		Adicionar ao Meu Espaço

IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function

Vallera, Daniel A ; Felices, Martin ; McElmurry, Ron ; McCullar, Valarie ; Zhou, Xianzheng ; Schmohl, Joerg Uwe ; Zhang, Bin ; Lenvik, Alexander J ; Panoskaltsis-Mortari, Angela ; Verneris, Michael R ; Tolar, Jakub ; Cooley, Sarah ; Weisdorf, Daniel J ; Blazar, Bruce R ; Miller, Jeffrey S

Clinical cancer research, 2016-07, Vol.22 (14), p.3440-3450 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
3
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation

Romee, Rizwan ; Cooley, Sarah ; Berrien-Elliott, Melissa M. ; Westervelt, Peter ; Verneris, Michael R. ; Wagner, John E. ; Weisdorf, Daniel J. ; Blazar, Bruce R. ; Ustun, Celalettin ; DeFor, Todd E. ; Vivek, Sithara ; Peck, Lindsey ; DiPersio, John F. ; Cashen, Amanda F. ; Kyllo, Rachel ; Musiek, Amy ; Schaffer, András ; Anadkat, Milan J. ; Rosman, Ilana ; Miller, Daniel ; Egan, Jack O. ; Jeng, Emily K. ; Rock, Amy ; Wong, Hing C. ; Fehniger, Todd A. ; Miller, Jeffrey S.

Blood, 2018-06, Vol.131 (23), p.2515-2527 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
4
Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen
Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen
Material Type:
Artigo 		Adicionar ao Meu Espaço

Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen

Foley, Bree ; Cooley, Sarah ; Verneris, Michael R ; Curtsinger, Julie ; Luo, Xianghua ; Waller, Edmund K ; Anasetti, Claudio ; Weisdorf, Daniel ; Miller, Jeffrey S

The Journal of immunology (1950), 2012-11, Vol.189 (10), p.5082-5088 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
5
Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein
Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein

Bachanova, Veronika ; Cooley, Sarah ; Defor, Todd E. ; Verneris, Michael R. ; Zhang, Bin ; McKenna, David H. ; Curtsinger, Julie ; Panoskaltsis-Mortari, Angela ; Lewis, Dixie ; Hippen, Keli ; McGlave, Philip ; Weisdorf, Daniel J. ; Blazar, Bruce R. ; Miller, Jeffrey S.

Blood, 2014-06, Vol.123 (25), p.3855-3863 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
6
One-Unit versus Two-Unit Cord-Blood Transplantation for Hematologic Cancers
One-Unit versus Two-Unit Cord-Blood Transplantation for Hematologic Cancers
Material Type:
Artigo 		Adicionar ao Meu Espaço

One-Unit versus Two-Unit Cord-Blood Transplantation for Hematologic Cancers

Wagner, John E ; Eapen, Mary ; Carter, Shelly ; Wang, Yanli ; Schultz, Kirk R ; Wall, Donna A ; Bunin, Nancy ; Delaney, Colleen ; Haut, Paul ; Margolis, David ; Peres, Edward ; Verneris, Michael R ; Walters, Mark ; Horowitz, Mary M ; Kurtzberg, Joanne

The New England journal of medicine, 2014-10, Vol.371 (18), p.1685-1694 [Periódico revisado por pares]

Waltham, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
7
Clinical utility of natural killer cells in cancer therapy and transplantation
Clinical utility of natural killer cells in cancer therapy and transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical utility of natural killer cells in cancer therapy and transplantation

Knorr, David A ; Bachanova, Veronika ; Verneris, Michael R ; Miller, Jeffrey S

Seminars in immunology, 2014-04, Vol.26 (2), p.161-172 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets
CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets
Material Type:
Artigo 		Adicionar ao Meu Espaço

CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets

Gleason, Michelle K. ; Ross, Julie A. ; Warlick, Erica D. ; Lund, Troy C. ; Verneris, Michael R. ; Wiernik, Andres ; Spellman, Stephen ; Haagenson, Michael D. ; Lenvik, Alexander J. ; Litzow, Mark R. ; Epling-Burnette, Pearlie K. ; Blazar, Bruce R. ; Weiner, Louis M. ; Weisdorf, Daniel J. ; Vallera, Daniel A. ; Miller, Jeffrey S.

Blood, 2014-05, Vol.123 (19), p.3016-3026 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
9
Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood
Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood
Material Type:
Artigo 		Adicionar ao Meu Espaço

Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood

Brunstein, Claudio G. ; Gutman, Jonathan A. ; Weisdorf, Daniel J. ; Woolfrey, Ann E. ; DeFor, Todd E. ; Gooley, Theodore A. ; Verneris, Michael R. ; Appelbaum, Frederick R. ; Wagner, John E. ; Delaney, Colleen

Blood, 2010-11, Vol.116 (22), p.4693-4699 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
10
Natural killer–cell differentiation by myeloid progenitors
Natural killer–cell differentiation by myeloid progenitors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Natural killer–cell differentiation by myeloid progenitors

Grzywacz, Bartosz ; Kataria, Nandini ; Kataria, Niketa ; Blazar, Bruce R. ; Miller, Jeffrey S. ; Verneris, Michael R.

Blood, 2011-03, Vol.117 (13), p.3548-3558 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (304)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (417)
  2. Book Chapters  (3)
  3. Reports  (2)
  4. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2004  (11)
  2. 2004Até2008  (39)
  3. 2009Até2013  (98)
  4. 2014Até2019  (186)
  5. Após 2019  (90)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.